Latest Medical Research News and Research
Updated: 55 min 6 sec ago
Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy.
Neurodegenerative diseases like Alzheimer’s and Parkinson’s are defined by pathogenic accumulation of toxic proteins in the brain.
Research from a new study suggests that health anxiety among the clinically vulnerable groups who shielded at home has risen since the first pandemic wave, despite developments in viral treatment and the roll-out of the vaccination programme.
Most therapeutic antibodies for treating COVID-19 patients do not inhibit emerging Omicron subvariants
The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current uptick of cases in Germany.
Researchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies.
A new study has reported two renal transplant cases, in which individuals, after being exposed to remdesivir, developed a resistance to the drug.
A new study examined the association of weight growth patterns during infancy and fetal periods with carotid distensibility and cIMT in children who are 10 years of age.
Researchers explored the molecular basis for increased immunity against heterologous SARS-CoV-2 strains after repeated antigen exposures.
A recent study investigated the effects of thiol drugs on SARS-CoV-2.
Study evaluates if adults with obesity and a history of SARS-CoV-2 infection demonstrate poorer T cell immunity
Researchers assessed the association between obesity and T cell frequencies specific to the SARS-CoV-2 antigen.
The impact of pre-existing immunity on mRNA booster doses of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2
Researchers assessed the impact of pre-existing immunity on mRNA booster doses of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2.
The identification and characterization of a thermophilic Cas13a ortholog highly active at the temperatures required for RT-LAMP
Researchers developed a new detection assay for SARS-CoV-2.
How sleep distress associated with melatonin imbalance may play a role in the presence, intensity, and severity of anosmia
In a recent study published in the International Journal of Developmental Neuroscience, researchers assessed the role of melatonin in COVID-19-associated anosmia.
HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.
As we head outdoors this summer, scientists are working to clip the long, flexible appendages that enable the common bacterium Campylobacter jejuni to make its way from undercooked poultry and natural waterways into our intestinal tract where it makes millions of us sick each year.
In a recent article posted to the bioRxiv* preprint server, researchers at Rutgers, the State University of New Jersey, the University of South Florida, and the Catholic University of America demonstrated that the natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) mutations result in nirmatrelvir resistance.
A recent study posted to the bioRxiv* preprint server supports using mosaic sarbecovirus receptor-binding domain (RBD)-nanoparticles to discover therapeutic pan-variant and pan-sarbecovirus monoclonal antibodies (mAbs) and to induce mAbs by vaccination.
In a recent study published in the BMJ, researchers investigated the factors that might influence the long-distance (more than two meters) airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in real-world indoor settings, e.g., workplaces and residential apartments.
In a recent study published in the New England Journal of Medicine, researchers evaluated the effectiveness of the BNT162b2 vaccine against the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron in five to 11-year-old children.
In a recent study published in The Lancet Infectious Diseases, researchers investigated the neutralization sensitivity of the emerging Omicron sub-variants, BA.2.12.1, BA.4, and BA.5.